Therefore, based on these findings, increasing irisin levels and upregulating browning and beiging of WAT can be a new therapeutic strategy to treat obesity and improve insulin sensitivity to prevent GDM in overweight and obese pregnant women. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.